CMS advises SYNLAB on sale of significant parts of its Eastern European laboratory diagnostic business

CMS has advised SYNLAB International GmbH, a leading provider of medical diagnostics in Europe, on the sale of significant parts of its activities in Eastern Europe, specifically the SYNLAB entities in Romania, Croatia, Cyprus, North Macedonia, Slovenia and Turkey, to Medicover Group.

This divestment transaction aligns with SYNLAB’s overarching strategy to densify its network by focusing on countries that offer strategic opportunities for SYNLAB Group’s further development.

The buyer, Medicover Group, is a European healthcare and diagnostic services company and operates a large number of ambulatory clinics, hospitals, laboratories and blood-collection points.

Rodica Manea, corporate M&A partner, Romania: “We are proud to have advised Synlab on the Romanian aspects of this complex deal that required a huge cross-border and local effort and commitment from all parties involved. It’s an excellent example of our bench strength and ability to deliver significant transactions across multiple jurisdictions. We are confident that Medicover Group will continue to provide exceptional healthcare and diagnostic services in the Romanian market.”

The transaction was managed by a cross-disciplinary CMS team, spanning multiple jurisdictions and led by CMS Germany Corporate/M&A Partner Dr. Christoph Lächler, who provided comprehensive legal advice to SYNLAB International on the entire transaction.

CMS’ advice on the Romanian aspects of transaction was led by Corporate/M&A partner Rodica Manea, and included counsel Raluca Ionescu, associate Simona Strava-Stoica, and associate Rares Crismaru (Corporate/M&A), senior counsel Claudia Nagy and associate Cristina Ciomos - Pop (Antitrust, Competition & Trade); senior associate Alexandru Dumitrescu and associate Aura Georgiana Marina (Real Estate).

Local CMS teams in Zagreb, Skopje, Ljubljana and Istanbul advised Croatian law, North Macedonian law, Slovenian law, and Turkish law.